Assessment of amiodarone effects on intact cats' electrocardiograms

Assessment of amiodarone effects on intact cats' electrocardiograms

Amiodarone can be used for treatment of ventricular and supraventricular arrhythmias in canine medicine, but its exact role in feline electrocardiography and its side effects have not been proven. The aim of this study was the evaluation of amiodarone and its different dosages effects on intact feline heart electrocardiograms. Eight healthy stray cats were selected and control electrocardiogram was obtained. Amiodarone tablets were prescribed twice daily at 10 mg/kg for 7 days. The same protocol was repeated with doses of 15 and 25 mg/kg. Hexagonal electrocardiograms were obtained at the end of each stage. Electrocardiograms were evaluated for P amplitude and duration, QRS duration, R amplitude, QT interval, PR interval, and heart rate changes. All data were compared with the control and between groups electrocardiograms. Obvious changes were seen in PR interval, QT interval, and heart rates in all dosages but P duration changes were seen only with the 25 mg/kg dosage. We used the same doses that were recommended in canine medicine. This study showed that 10 mg/kg of amiodarone has no visible changes in cats electrocardiograms, but a toxic dose and even the dose of 15 mg/kg produced some obvious changes. Therefore, more studies are necessary to find the proper amiodarone doses in cats.

___

  • 1. Willms, C., Kirby, R., Rudloff, E.: Cardiopulmonary resuscitation update: stepping outside the box. Compendium, 2002; 24: 922–932.
  • 2. Tsagalou, E.P., Anastasiou-Nana, M.I., Siafakas, K.X., Panagiotopoulos, G.G., Doufas, A.G., Ntalianis, A.S., Terrovitis, J.V., Drakos, S.G., Mavrikakis, J.M., Charitos, C.E., Nanas J.N.: Time course of ventricular fibrillation and defibrillation thresholds following amiodarone intravenous bolus administration: an experimental study. Hellenic J. Cardiol., 2003; 44: 14–23.
  • 3. Oliveira, P.F., Dias da Silva, V.J., Salgado, M.C.O., Fazan, R., Aguiar, C.A., Salgado, H.C.: Acute effect of amiodarone on cardiovascular reflexes of normotensive and renal hypertensive rats. Braz. J. Med. Biol. Res., 2005; 38: 967–976.
  • 4. Ettinger, S.J.: Therapy of arrhythmias. In: Ettinger, S.J., Feldmen, E.C., Eds. Textbook of Veterinary Internal Medicine. 7th edn., Vol. 1, W.B. Saunders Co., St. Louis. 2010; 1234–1235.
  • 5. Ware, W.A.: Cardiac arrhythmias and antiarrhythmic drugs. In: Nelson, R.W., Couto, C.G., Eds. Small Animal Internal Medicine. 3rd edn., Mosby, St. Louis. 2003; 78–81.
  • 6. Bonagura, J.D., Schober, K.E.: Cardiovascular drugs. In: Birchard, S.J., Sherding, R.G., Eds. Saunders Manual of Small Animal Practice. 3rd edn. W.B. Saunders Co., St. Louis. 2006; 1490–1493.
  • 7. Nishimura, M., Follmer, C.H., Singer, D.H.: Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther., 1989; 251: 650–659.
  • 8. Watanabe, Y., Hara Y., Tamagawa, M., Nakaya, H.: Inhibitory effect of amiodarone on the muscarinic acetylcholine receptoroperated potassium current in guinea pig atrial cells. J. Pharmacol. Exp. Ther., 1996; 279: 617–624.
  • 9. Da Silva, V.J.D., Gnecchi-Ruscone, T., Lavelli, B., Bellina, V., Manzella, D., Porta, A., Malliani, A., Montano, N.: Opposite effects of IV amiodarone on cardiovascular vagal and sympathetic efferent activities in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000; 283: 543–548.
  • 10. Hughes, M., Binning, A.: Intravenous amiodarone in intensive care. Int. Care Med., 2000; 26: 1730–1739.
  • 11. Cheung, A.T., Weiss, S.J., Savino, J.S., Levy, W.J., Augoustides, J.G., Harrington, A., Gardner, T.J.: Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. Ann. Thorac. Surg., 200; 76: 535–541.
  • 12. Chimienti, M., Gallone, G., Barbieri, S., Bruni, F., Arlotti, M.: Comparison of oral and intravenous loading dose of amiodarone for converting recent-onset atrial fibrillation. Ital. Heart J., 2002; 5: 217.
  • 13. Gotsis, A., Terzi, S., Dourtsiou, S., Alexoudis, A., Panagiotidou, A.: Comparison of amiodarone and propafenone in the conversion of paroxysmal atrial fibrillation. Ital. Heart J., 2004; 5: 217.
  • 14. Van Isra, N.: Idiopathic dilated cardiomyopathy in the dog: treatment modalities. J. Small Anim. Cardiol., 2004; 9: 1–6.
  • 15. Gordon, S.G., Kittleson, M.D.: Drugs used in the management of heart failure and cardiac arrhythmic. In: Maddison, J.E., Page, S.W., Church, D.B., Eds. Small Animal Clinical Pharmacology. 2nd edn., W.B. Saunders Co., St. Louis. 2008; 400–402.
  • 16. Donald, K.M.: Drug used for ventricular arrhythmias. In: Morgan, R.V., Ed. Handbook of Small Animal Practice. 5th edn., W.B. Saunders Co., St. Louis. 2008; 63–65.
  • 17. Ramsey, I.: Amiodarone. In: Ramsey, I., Ed. BSAVA Small Animal Formulary. 6th edn., British Small Animal Veterinary Association, Rhondda. 2008; 15–16.
  • 18. Kadish, A.H., Chen, R.F., Schmaltz, S., Morady, F.: Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. J. Am. Cardiol., 1999; 16: 1240–1245.
  • 19. Gloor, H.O., Urthaler, F., James, T.N.: Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. J. Clin. Invest., 1983; 71: 1457–1466.
  • 20. Kodama, I., Kamiya, K., Toyama, J.: Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am. J. Cardiol., 1999; 84: 20–28.
  • 21. Bacq, Z.M., Blakeley, A.G., Summers, R.J.: The effects of amiodarone, an alpha and beta receptor antagonist, on adrenergic transmission in the cat spleen. Biochem. Pharmacol., 1976; 25: 1195–1199.
  • 22. Du, X.J., Esler, M.D., Dart, A.M.: Sympatholytic action of intravenous amiodarone in the rat heart. Circulation, 1995; 91: 462–470.
  • 23. Webster, C.R.L.: Clinical Pharmacology. 1st edn., Teton NewMedia, Jackson, WY, USA. 2001; 35.
  • 24. Shaikh, N.A., Downar, E.: Effects of chronic amiodarone treatment on cat myocardial phospholipid content and on in vitro phospholipid catabolism. Mol. Cell. Biochem.., 1987; 78: 17–25.
  • 25. Naito, M., Michelson, E.L., Kmetzo, J.J., Kaplinsky, E., Dreifus, L.S.: Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Am. Heart Assoc., 1981; 63: 70–79.
  • 26. Miller, M.W., Adams, H.R.: Antiarrhythmic agents. In: Riviere, J.E., Papich, M.G., Eds. Veterinary Pharmacology and Therapeutics. 9th edn. Wiley-Blackwell, Hoboken, NJ, USA. 2009; 591–593.